Literature DB >> 11076046

Identification of four novel mutations in five unrelated Korean families with Fabry disease.

J K Lee1, G H Kim, J S Kim, K K Kim, M C Lee, H W Yoo.   

Abstract

Fabry disease is a X-linked recessively inherited metabolic disorder, which results from the deficient activity of the lysosomal hydrolase alpha-galactosidase A leading to the systemic deposition of glycosphingolipids with terminal alpha-galactosyl moieties. Single-strand conformation polymorphism (SSCP) analysis was performed, followed by DNA sequencing of PCR amplified exons of the human alpha-galactosidase A gene in 5 unrelated Korean patients with classic Fabry disease. Five different mutations were identified; two nonsense mutations (Y86X and R342X), one missense mutation (D266N), and two small deletions (296del2 and 802del4). Except for R342X mutation, four were novel mutations (Y86X, D266N, 296del2, 802del4). A T to G transversion at nucleotide position 5157 in exon 2 caused a tyrosine-to-stop substitution at codon 86. A G to A transition at position 10287 in exon 5 substituted an asparagine for an aspartate at codon 266. Mutation 296del2 in exon 2 resulted in a frame shift with a stop signal at the 22th codon downstream from the mutation, whereas mutation 802del4 resulted in a stop codon at the site of 4 bp deletion. In addition, the 802del4 was found to be a de novo mutation. This is the first report on mutation analysis of the human alpha-galactosidase A gene in Korean patients with Fabry disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076046     DOI: 10.1034/j.1399-0004.2000.580311.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

Review 1.  Renal pathological changes in Fabry disease.

Authors:  A Sessa; M Meroni; G Battini; A Maglio; P L Brambilla; M Bertella; M Nebuloni; F Pallotti; F Giordano; B Bertagnolio; A Tosoni
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Structure-function relationships in alpha-galactosidase A.

Authors:  Scott C Garman
Journal:  Acta Paediatr       Date:  2007-04       Impact factor: 2.299

Review 3.  Fabry's disease: an example of cardiorenal syndrome type 5.

Authors:  Aashish Sharma; Marco Sartori; Jose J Zaragoza; Gianluca Villa; Renhua Lu; Elena Faggiana; Alessandra Brocca; Luca Di Lullo; Sandro Feriozzi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

4.  Structural characterization of mutant alpha-galactosidases causing Fabry disease.

Authors:  Kanako Sugawara; Kazuki Ohno; Seiji Saito; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2008-07-17       Impact factor: 3.172

Review 5.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

6.  A Novel Frameshift Mutation of Galactosidase-alpha in Fabry Disease Restricted to Dermatologic Manifestations.

Authors:  Dae Hun Kim; Soo Yeon Kim; Myung Im; Young Lee; Young Joon Seo; Jeung Hoon Lee
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

7.  Short-term efficacy of enzyme replacement therapy in Korean patients with Fabry disease.

Authors:  Jin-Ho Choi; Young Mi Cho; Kwang-Sun Suh; Hye-Ran Yoon; Gu-Hwan Kim; Sung-Su Kim; Jung Min Ko; Joo Hoon Lee; Young Seo Park; Han-Wook Yoo
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.